Author Information
Harvey Owen Coxson is a distinguished researcher affiliated with Boehringer Ingelheim Pharma GmbH & Co., India. His work predominantly revolves around pulmonary research, with a strong focus on diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). His extensive involvement in the field has significantly contributed to understanding respiratory illnesses, both at the molecular and clinical levels.Research Contributions
Harvey Owen Coxson has made substantial contributions to respiratory research, particularly in the study of lung diseases. In 2022, he explored the divergent gene expression in lung tissues between COPD and IPF, adding valuable insights into the pathophysiology of these conditions. His 2021 publications delved into various aspects of lung health, including the destruction of terminal bronchioles in COPD, the role of pectoralis muscle area in interstitial lung disease, and the use of computed tomography in predicting disease progression. His research not only deepens the understanding of respiratory diseases but also aids in developing potential diagnostic and therapeutic strategies.Aliases
Harvey Owen Coxson is known by various aliases in academic publications, including H. Coxson, Harvey O. Coxson, Harvey\u2002o. Coxson, H Coxson, H. O. Coxson, and H O Coxson. These variations are used interchangeably across his scholarly works.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
310 |
| Total Citations |
23,928 |
| h-index |
80 |
